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Abstract:  
 
Introduction: Syphilis remains an important and preventable cause of stillbirth and neonatal 
mortality. About 1 million women with active syphilis become pregnant each year.  Without 
treatment, 25% of them will deliver a stillborn baby and 33% a low birth weight baby with an 
increased chance of dying in the first month of life. Adverse pregnancy outcomes due to 
syphilis can be prevented by screening pregnant women, and treating those who test positive 
with a single dose of penicillin before 28 weeks gestation.  
Areas covered:   
 The impact of syphilis on pregnancy outcome 
 The diagnosis of syphilis, with a special focus on point of care (POC) tests 
 Challenges to the introduction of POC tests, and their potential impact on the control 
and prevention of syphilis in resource limited settings 
1. Expert commentary: POC tests for syphilis are available which meet the ASSURED 
criteria, and could make syphilis screening accessible to all women anywhere in the world 
who attend an antenatal clinic. High quality dual POC tests for HIV and syphilis could ensure 
that well funded programmes for the prevention of mother to child transmission of HIV can 
contribute towards increased coverage of antenatal syphilis screening, and prevent more than 
300,000 adverse pregnancy outcomes due to syphilis annually. Alongside investment to 
increase   availability of syphilis POC tests, operational research is needed to understand how 
best to improve screening of pregnant women and to translate test availability into improved 
pregnancy outcomes.  
 
 
 
2. Introduction 
Syphilis is caused by the bacterium Treponema pallidum, and can be cured with a single dose 
of long acting penicillin.  It is transmitted between partners during sexual intercourse, and 
from infected pregnant women across the placenta to the developing foetus.  
  
The clinical manifestations of syphilis can are classicallybe divided into three stages. The 
primary chancre is an ulcer, usually painless, at the site of inoculation. It heals after a few 
weeks even in the absence of treatment. Some weeks later, the secondary stage occurs, 
usually with a generalised rash and symptoms involving many body systems. This also 
resolves, usually over weeks or months, in the absence of treatment, and is followed by the 
latent stage, in which the patient has no symptoms or clinical signs. Most women who 
transmit syphilis to their infant have latent syphilis, and can only be identified by screening 
programmes.  The tertiary stage may occur many years later, affecting the skin, central 
nervous or cardiovascular systemssystems [1,2]. 
 
The WHO estimates there are about 6 million new cases of syphilis per year. Amongst 
women of child bearing age the , with the highest burden is in sub-Saharan Africa [3].  In 
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2012, about 1 million pregnant women globally were estimated to have active syphilis but, in 
sub-Saharan Africa, less than 50% of pregnant women attending antenatal clinic were 
screened for syphilis [4]. A study in Tanzania showed that, among women with syphilis who 
were not treated, 25% delivered a stillborn baby, and 33% a low birth weight baby [5].  These 
adverse pregnancy outcomes can be prevented by a single dose of long acting benzathine 
penicillin given before 28 weeks gestation [6].  
 
Appropriate diagnostics and early treatment are crucial in preventing long-term complications 
of syphilis and mother-to-child transmission (MTCT).  Screening pregnant women for 
syphilis is one of the most cost effective health interventions.  Terris-Prestholt et al found that 
in Mwanza, Tanzania, where the prevalence of active syphilis in pregnant women was 6%, 
the cost per disability-adjusted life year (DALY) saved was $10.56, if the impact on 
stillbirths averted is included [7].  Screening remains highly cost-effective at a prevalence of 
2% among antenatal patients, at $33 per DALY saved.  Congenital syphilis and adverse 
pregnancy outcomes due to untreated syphilis represent a missed opportunity for disease 
prevention.  
 
3.1. The Diagnosis of Syphilis 
 
Appropriate diagnostic techniques are vital for the control of syphilis, which requires 
screening and case-finding, since most people with syphilis have no symptoms. Latent 
syphilis is diagnosed in individuals with reactive serologicallyserological tests but no clinical 
features of early or late syphilis. There are two types of antibody test: treponemal  
andtreponemal and non-treponemal. Treponemal tests are specific and detect antibodies to T. 
pallidum. They include the T. pallidum haemagglutination assay (TPHA), T.pallidum particle 
agglutination assay (TPPA), fluorescent treponemal antibody absorption (FTA-Abs), 
treponemal enzyme immunoassay (EIA) and a number of point-of-care (POC) tests.  Once 
positive, treponemal tests remain positive for life.  
 
3.2.1.2. Laboratory based tests 
 
Non-treponemal tests include the venereal diseases research laboratory (VDRL) test, and the 
rapid plasma reagin (RPR) test, which has the advantage of not requiring a microscope. Non-
treponemal tests are less specific than treponemal tests, and false positive results are more 
common in pregnant women.  Unlike the treponemal tests, non-treponemal tests usually 
revert to negative some months after successful treatment, and falling titres can be used to 
monitor the response to treatment.  Neither treponemal nor non-treponemal tests can 
distinguish between syphilis and the non-venereal treponematoses (yaws, pinta and endemic 
syphilis). 
 
3.3.1.3. Point of care tests 
Until recently diagnostic tests for syphilis haves been inaccessible in many resource limited 
settings, as the older tests require technical expertise, equipment and electricity. , POC tests 
are now available which do not require equipment, can be stored at room temperature, and 
can give a result in 15 minutes, enabling syphilis to be diagnosed at the point of care, without 
the need for a  laboratorya  . laboratory. A diagnosis can be made at the first visit, so that 
patients do not have to return for their results, and treatment can be given immediately: 
‘Same-day Testing and Treatment’ (STAT).   Almost every country has a policy for antenatal 
syphilis screening and, now that these tests are available, all pregnant women who attend 
antenatal clinic can be screened and treated.   
 
A number of syphilis POC tests are available, many of which fulfil the ASSURED criteria [8] 
(Tables 1 and 2).   
Table 1: The ASSURED criteria 
 
ASSURED 
Affordable by those at risk of infection 
Sensitive (few false-negatives) 
Specific (few false-positives) 
User-friendly (simple to perform and requiring minimal training) 
Rapid (to enable treatment at first visit) and Robust (does not require refrigerated 
storage) 
Equipment-free 
Delivered to those who need it 
 
These are mostly treponemal tests, which remain positive for life, but POC tests have recently 
become available which identify both treponemal and non-treponemal antibodies. They are 
mostly immuno-chromatographic strip (ICS) based assays whichassays, which can be used 
with whole blood, serum or plasma.  Antigen-antibody reactions appear as a coloured line or 
spot on the membrane.  The majority of the tests on the market fulfil the ASSURED criteria, 
though they vary in their sensitivity, and sensitivity is reduced when using whole blood rather 
than plasma or serum [9].  A systematic review by Tucker et al identified 15 studies 
evaluating syphilis POC tests, representing 23,055 individual test results [10]. Thirteen of the 
studies were from low or middle-income countries, and all were performed in an ANC or STI 
clinic setting.  The median ICS syphilis test sensitivity was 86% (interquartile range [IQR] 
75% - 94%).  The specificity of syphilis ICS tests ranged from 90.9-100.0% with a median of 
99%.   
 
Jafari et al carried out a systematic review of  POCof POC tests for syphilis using serum and 
whole blood samples [11].  Only POC tests that met the ASSURED criteria were included, of 
which 18 were identified. The majority were ICS based assays.  The meta-analysis showed 
that the Determine rapid test, using a serum sample, had the best estimate for sensitivity 
(92.03%, 95% CI 87.22- 95.77) and Syphicheck had the best specificity (99.44%, 95% CI 
98.96- 99.81), compared to a laboratory based treponemal test.  In all comparisons the 
estimated sensitivity was higher using serum than using whole blood  
Combined treponemal and non-treponemal dual ICS POC tests have recently become 
available which enable health care workers to distinguish between active syphilis and past, 
treated infection (Table 2). The Dual Path Platform test was the first of these, and has been 
shown to have good sensitivity and specificity in a variety of settings, although the sensitivity 
is decreased at low RPR titres [12]. In theory these tests could be used to monitor the 
response to treatment, since the non-treponemal test should revert to negative, but they have 
not yet been evaluated as a test of cure.  
 
4.2. The Impact of POC testing for Syphilis 
 
POC tests have been shown to increase the uptake of screening for syphilis in a variety of 
resource limitedsettingslimited settings...  Treponemal POC tests have been rolled out, and 
their impact evaluated in rural antenatal care clinics in Tanzania, Uganda and China; both 
rural and urban clinics in Peru and Zambia; and in remote indigenous communities in Brazil 
[13].  The introduction of POC tests increased the proportion of antenatal care attenders 
screened for syphilis to 90%, and the proportion of pregnant women with syphilis who were 
treated the same day exceeded 90% in all countries. Modelling from this study has shown that 
POC tests are more cost-effective in screening and treating syphilis than laboratory-based 
testing methods such as the RPR [14].  POC tests for syphilis were rolled out nationally in 
China in 2010, after these studies were completed.  Between 2012 and 2014 the number of 
people reported to the National Centre for STD Control as having been tested for syphilis 
increased from 4.2 million to 29.6 million per year [Chen X, personal communication].  
 
Strasser et al conducted a field acceptability and feasibility study of including treponemal 
POC syphilis testing within  PMTCTwithin PMTCT HIV programmes in Uganda and 
Zambia [15]. Significant increases in syphilis testing and treatment using a POC test were 
demonstrated, especially in Uganda, where access to syphilis testing was previously limited, 
with only 4% of women who attended ANC being tested for syphilis in rural Jinja District.  
Post intervention a huge increase was seen;  99.7% of women were tested (p<0.0001), and 
97.8% received STAT.  There was no deterioration in HIV services with the addition of the 
rapid syphilis test. Bronzan et al  hadal had similar results in rural antenatal clinics in South 
Africa, where the on site POC test resulted in the 89% of pregnant women being correctly 
diagnosed and treated for syphilis, compared with 61% at standard practice clinics [16]. 
 
The World Health Organization (WHO) has acknowledged the value of POC testing for 
syphilis, and the opportunity it provides for universal screening of pregnant women.  In 2007 
it launched the Initiative for the Global Elimination of Mother to Child Transmission 
(MTCT) of both HIV and Syphilis [17].  Their goal is for 90% of pregnant women to be 
tested for HIV and syphilis, and for at least 90% of seropositive pregnant women to receive 
treatment.  The major investment in HIV PMTCT programmes in many low and middle 
incomemiddle-income countries in recent years offers an important opportunity to increase 
the uptake of syphilis screening.  The London School of Hygiene and Tropical Medicine 
provides a toolkit, available on line, on how two such programmes can be integrated [18].  
Considerable progress has been made since 2007, with 5 countries so far validated as having 
achieved the dual elimination targets [19]. The new, dual syphilis and HIV POC tests have 
the potential to accelerate this process [20].   
 
Point of care tests have also been used to screen hard-to-reach populations. In Brazil, health 
care workers in remote communities succeeded in screening 55% of the sexually active 
population (defined as ≥10 years of age) for syphilis, exceeding the 30%–40% target 
originally set [13].  Modelling studies have estimated the impact of using rapid tests to screen 
female sex workers for syphilis and shown that screening with POC tests could dramatically 
reduce syphilis prevalence amongst this hard-to-reach group, but strategies to reduce re-
infection from regular non-commercial partners are needed to maximise impact [21].  
 
5.3. Challenges in the implementation of POC testing 
4.1 Training and logistics 
Introducing POC tests can be challenging in resource limited settings, where a small cadre of 
often overworked health care workers need to be trained, and provided with incentives to 
undertake additional work.  Ensuring a regular supply of POC tests can also be challenging.  
The roll out of POC testing for syphilis in antenatal clinics in Ghana made it possible to 
screen women in clinics where screening had not previously been available but, 
paradoxically, coverage actually decreased in larger clinics that had previously had access to 
laboratory testing.  This was attributed to frequent stockouts of POC tests in the region [20].  
A second study in Ghana found that pregnant women seeking antenatal care in the private 
sector were not screened for syphilis, since the rollout of POC tests had only included public 
sector health facilities [23]. 
 
5.2.3.2. Quality Assurance 
As countries begin to implement POC testing, adequate external quality assurance (QA) 
programmes must be developed in parallel. These are routinely implemented in most 
laboratories, but have been largely neglected in the case of POC tests.  Montoya et al noted 
the accuracy of the POC testing was greater when used by laboratory staff with higher levels 
of training and in a setting with better infrastructure and supervision than when carried out by 
staff at health facilities [24]. It is clearly important that health workers using the test are 
properly trained and well supervised, but it is also important to monitor their performance 
regularly and offer remedial training to those who do not meet the required standard.   
 
Two approaches to external QA have been piloted in the case of syphilis POC tests: the use 
of a proficiency panel consisting of dried positive and negative serum samples that can be 
reconstituted in the clinic has been evaluated in the Amazonas region of Brazil [25]; and the 
collection of dry blood spots at the point of care, which can be re-tested in the laboratory, has 
been piloted in rural Tanzania [26] In Brazil 268 healthcare workers tested 5 samples each, 
9.3% of all samples tested were diagnosed incorrectly and 4.1% of healthcare workers 
reported difficulties with the POC tests. This method enabled remedial action to be taken 
when an incorrect result was obtained.  The Tanzanian study was based in six villages in 
northern Tanzania.  The conclusion was that DBS samples can be recommended for use with 
TPPA, and may be of value for external QA of POC syphilis tests.  
 
6.4. Five year view 
POC tests make it possible to screen all pregnant women who attend ANC for syphilis, and to 
treat them immediately.  What is needed now is advocacy to convince governments, funding 
agencies and health programme managers that this is an important and worthwhile objective, 
and that syphilis screening should be a political and healthcare priority. The proposal for the 
creation of a WHO Essential Diagnostics List may provide a platform to further raise the 
profile of syphilis POC test kits.  Alongside advocacy operational research is needed to 
identify the best strategies to increase access to ANC syphilis screening and to translate 
availability of POC tests in to improved pregnancy outcomes. The tools are available; the 
next step is to make understand how to effectively make them available to all.    
 
A recent study in Peru has shown that the roll out of POC tests offers an opportunity to 
improve other aspects of health systems as well as increasing coverage of syphilis screening 
[27]. Widespread adoption and use of POC tests depends on engaging the authorities; 
dissipating tensions between providers and identifying champions; training according to the 
needs of health care workers; providing monitoring, supervision, support and recognition; 
sharing results and discussing actions together; consulting and obtaining feedback from  
clientsfrom clients and from those tasked with performing POC tests; and integrating syphilis 
screening with other services such as with rapid HIV testing.  
 
There is limited published data on nationwide scale up of syphilis POC tests in low-income 
settings. In a small pilot study in Mozambique increased access to POC tests did not result in 
an increase in the proportion of women receiving syphilis screening [28]. In studies 
conducted alongside the scale of syphilis POC tests in Zambia health-care acceptability of 
testing was high but potential barriers to implementation including stock-outs of both POC 
tests and penicillin were identified [29]. A health-systems based approach will be of value in 
supporting all elements of the scale-up of syphilis POC tests worldwide. 
 
 
Given the limited data from low-income settings it may be valuable to draw parallels with the 
roll-out of POC tests for other infectious diseases such as malaria. Whilst a number of 
accurate malaria POC test kits are available this has not always translated into improved 
targeting of anti-malarials in patients presenting with fever. Ethnographic studies have 
demonstrated that both healthcare worker and patient beliefs as well as structural factors 
affect how test results are translated into clinical actions [30]. Appropriately tailored training 
programmes are required to translate effective tests into improved outcomes [31]. Similar 
implementation research is urgently required to support the scale up of POC syphilis tests. 
 
, POC tests can be used  forused for self-testing outside of a clinical setting through 
community-based organizations, in pharmacies or at home. Home-based testing for HIV has 
been shown to reach wide sections of communities in a diverse range of contexts and settings, 
providing  earlyproviding early access to treatment [32]. Decentralizing testing for curable 
STIs may increase access to testing and awareness of STIs, but linkage to clinical care will be 
essential for diagnostic confirmation, treatment, counselling and follow-up [33]. As with 
facility based testing further implementation research is required to guide improved access to 
home based syphilis testing. 
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Table 2.  Point-of-care tests currently on the market with available sensitivities and 
specificities [68, 1012, 2834]* 
 
Test Sample-Type Test-Type Target Sensitivity 
(%) 
Specificity 
(%) 
Alere 
Determine 
Syphilis TP 
Whole 
blood/serum/plasma 
Treponemal 
POC 
Treponemal 
Antibody 
59.6-100 95.7-100 
Omega 
VisiTect 
Syphilis  
Whole 
blood/serum/ 
plasma 
Treponemal 
POC 
Treponemal 
Antibody 
72.7-98.2 98.1-100 
Qualpro 
Syphicheck-
WB 
Whole 
blood/serum/ 
plasma 
Treponemal 
POC 
Treponemal 
Antibody 
64-97.6 98.4-99.7 
SD Bioline 
Syphilis 3.0  
Whole blood/ 
serum/plasma 
Treponemal 
POC 
Treponemal 
Antibody 
85.7-100 95.5-99.4 
Dual Path 
Platform 
(DDP®) 
Syphilis Test 
(Chemio 
Diagnostic 
Systems, Inc) 
Whole blood/ 
serum/plasma 
Dual 
Treponemal 
& Non-
Treponemal 
Syphilis 
POC 
Treponemal 
Antibody 
90.1-98.2 91.2-98.0 
Non-
Treponemal 
Antibody 
80.6-98.2 89.4 
SD Bioline 
HIV/Syphilis 
Duo Rapid Test 
(Alere/Standard 
Diagnostics, 
Inc) 
Whole blood/ 
serum/plasma 
Combined 
Syphilis and 
HIV POC 
HIV 
Antibody 
97.9-99.0 99.0-100 
Treponemal 
Antibody 
93.0-99.6 99.1-100 
DPP® HIV-
Syphilis Assay 
(Chembio 
Diagnostic 
Systems, Inc) 
Whole blood/ 
serum/plasma 
Combined 
Syphilis and 
HIV POC 
HIV 
Antibody 
98.9 97.9-99.6 
Treponemal 
Antibody 
95.3 97.0-99.6 
Multiplo Rapid 
TP/HIV 
Antibody Test 
(MedMira, Inc) 
Whole blood/ 
serum/plasma 
Combined 
Syphilis and 
HIV POC 
HIV 
Antibody 
97.9 94.2-99.5 
Treponemal 
Antibody 
94.1 94.2-99.1 
* A number of other POC kits are commercially available, including kits not yet licensed by 
the FDA, for which there is not published sensitivity and specificity data within the public 
domain. 
 Key Issues 
 WHO estimates that there are 6 million new cases of syphilis per year 
 25% of pregnant women with syphilis deliver a stillborn baby 
 33% of pregnant women with syphilis deliver a low birth weight baby 
 Adverse pregnancy outcomes due to syphilis can be prevented with a single dose of 
penicillin delivered before 28 weeks’ gestation 
 Most countries in the world have a policy to screen all pregnant women for syphilis 
 Less than 50% of pregnant women are screened for syphilis in sub-Saharan Africa 
 Point of Care tests for syphilis are available which require only one drop of blood, give a 
result in 15 minutes, are sensitive, specific, require no equipment and cost less than $1 
 Studies in low and middle income countries have shown that these POC tests can greatly 
increase coverage of syphilis screening in pregnancy 
 Challenges in rolling out POC tests more widely include a shortage of trained health care 
workers, difficulties in maintaining the supply chain, and difficulties in quality assurance at 
the point of care 
 
Expert Commentary 
A number of POC tests for syphilis are available which fulfil the ASSURED  criteria.   While 
the sensitivity of some of these tests is slightly lower than that of laboratory-based tests, the 
cases that are missed are those with low RPR titres, which are unlikely to lead to adverse 
pregnancy outcomes [35].  The fact that these tests can be performed anywhere makes them 
far more accessible than laboratory-based tests, so that in theory it should be possible to test 
all women attending antenatal clinics for syphilis, and treat those who test positive, at their 
first visit. Unfortunately, although syphilis causes more stillbirths and neonatal deaths than 
HIV [2935],  it has not been considered a high priority by national governments or 
international funding agencies, which have concenttrated their efforts on screening pregnant 
women for HIV. The availability of dual HIV/syphilis POC tests, some of which have been 
shown to fulfil the ASSURED criteria and are available through the WHO bulk procurement 
programme, should make it possible to ensure that all women who are screened for HIV are 
also screened for syphilis. This would have the potential to save at least 300,000 adverse 
pregnancy outcomes per year. Alongside investment to increase availability of POC syphilis 
tests, operational research is needed to understand how best to improve screening of pregnant 
women and to translate test availability into improved pregnancy outcomes.  
 
